These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26347996)

  • 1. Influence of verapamil on pharmacokinetics of pristimerin in rats.
    Gao X; Zhang Y; Wang Y; Zhang Y; Wang Y; Liu S; Gao X
    Biomed Chromatogr; 2016 Jun; 30(6):802-9. PubMed ID: 26347996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption and metabolism characteristics of pristimerin as determined by a sensitive and reliable LC-MS/MS method.
    Dong C; Xu C; Liu H; Xu S; Gao Y; Peng J
    Fitoterapia; 2015 Oct; 106():62-7. PubMed ID: 26299424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Glycyrrhizic Acid on the Pharmacokinetics of Pristimerin in Rats and its Potential Mechanism.
    Zhao X; Wu Y; Wang D
    Eur J Drug Metab Pharmacokinet; 2018 Feb; 43(1):63-68. PubMed ID: 28631076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The drug-drug interaction of sorafenib mediated by P-glycoprotein and CYP3A4.
    Wang X; Zhang X; Huang X; Li Y; Wu M; Liu J
    Xenobiotica; 2016 Jul; 46(7):651-658. PubMed ID: 26582036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of verapamil on the pharmacokinetics of rotundic acid in rats and its potential mechanism.
    Shang H; Wang Z; Ma H; Sun Y; Ci X; Gu Y; Liu C; Si D
    Pharm Biol; 2021 Dec; 59(1):200-208. PubMed ID: 33595422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of verapamil on the pharmacokinetics of curculigoside in rats.
    Wang K; Zhao J; Lang J
    Pharm Biol; 2016 Dec; 54(12):3001-3008. PubMed ID: 27328778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Verapamil, a P-glycoprotein-1 and Cytochrome P450 3A4 Inhibitor, on Pharmacokinetics and Metabolic Stability of Ripretinib: A Drug-Drug Interaction Study in Rats.
    Mudavath S; Ashok D
    Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):733-746. PubMed ID: 37831396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of verapamil on the pharmacokinetics of dihydromyricetin in rats and its potential mechanism.
    Huang Y; Zhao J; Jian W; Wang G
    Xenobiotica; 2018 Aug; 48(8):839-844. PubMed ID: 28795912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of verapamil on the pharmacokinetics of puerarin in rats.
    Zhou Y; Song X; Dong G
    Xenobiotica; 2019 Oct; 49(10):1178-1182. PubMed ID: 30173622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Verapamil on Pharmacokinetics of Triptolide in Rats.
    Zhang Y; Li J; Lei X; Zhang T; Liu G; Yang M; Liu M
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):449-56. PubMed ID: 25854676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the influence of glycyrrhizin on the pharmacokinetics of celastrol in rats using LC-MS and its potential mechanism.
    Yan G; Zhang H; Wang W; Li Y; Mao C; Fang M; Yi X; Zhang J
    Xenobiotica; 2017 Jul; 47(7):607-613. PubMed ID: 27919190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism.
    Xing H; Luo X; Li Y; Fan C; Liu N; Cui C; Li W
    Pharm Biol; 2020 Dec; 58(1):152-156. PubMed ID: 31990625
    [No Abstract]   [Full Text] [Related]  

  • 13. Absorption and Metabolism Characteristics of Triptolide as Determined by a Sensitive and Reliable LC-MS/MS Method.
    Gong X; Chen Y; Wu Y
    Molecules; 2015 May; 20(5):8928-40. PubMed ID: 25993421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of verapamil on the pharmacokinetics of oridonin in rats.
    Liu J; Zhang N; Li N; Fan X; Li Y
    Pharm Biol; 2019 Dec; 57(1):787-791. PubMed ID: 31747844
    [No Abstract]   [Full Text] [Related]  

  • 15. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
    Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glycyrrhizin on the pharmacokinetics of puerarin in rats.
    Zhao Q; Wang Y; Wang H; Feng L
    Xenobiotica; 2018 Nov; 48(11):1157-1163. PubMed ID: 29099639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats.
    Bansal T; Mishra G; Jaggi M; Khar RK; Talegaonkar S
    Eur J Pharm Sci; 2009 Mar; 36(4-5):580-90. PubMed ID: 19135530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein.
    Liang Y; Zhou Y; Zhang J; Liu Y; Guan T; Wang Y; Xing L; Rao T; Zhou L; Hao K; Xie L; Wang GJ
    Phytomedicine; 2013 Aug; 20(11):1030-8. PubMed ID: 23731657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-drug interactions between moxifloxacin and rifampicin based on pharmacokinetics in vivo in rats.
    Huang L; Liu J; Yu X; Shi L; Liu J; Xiao H; Huang Y
    Biomed Chromatogr; 2016 Oct; 30(10):1591-8. PubMed ID: 27028459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil and pristimerin pharmacokinetic drug-drug interaction study in rats - perspectives.
    Srinivas NR
    Biomed Chromatogr; 2016 Dec; 30(12):2074. PubMed ID: 27444812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.